BackEditas Medicine Overview
Editas Medicine Inc

Editas Medicine Target Price

See Editas Medicine's analyst price targets ($4) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.68

Average Target Price

$4.0049.3% upside

1 analysts in the last 4 months

High: $4 | Low: $4

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-05Chardan Capital$449.3% upsideOpen
2026-03-09Robert W. Baird$6123.9% upsideOpen
2024-11-05BarclaysGena Wang$586.6% upsideOpen
2024-10-23Wells FargoYanan Zhu$9235.8% upsideOpen
2024-10-22Robert W. BairdJoel Beatty$10273.1% upsideOpen
2024-08-08Truist FinancialJoon Lee$12347.8% upsideOpen
2024-08-08Bank of America SecuritiesGreg Harrison$15459.7% upsideOpen
2024-05-30Evercore ISILiisa Bayko$7161.2% upsideOpen
2024-05-09Morgan StanleyMatthew Harrison$7161.2% upsideOpen
2023-09-28Stifel NicolausDae Gon Ha$17534.3% upsideOpen
2022-12-13Citigroup$11310.4% upsideOpen
2022-11-18Morgan Stanley$8198.5% upsideOpen
2022-11-18RBC Capital$14422.4% upsideOpen
2022-11-18Truist FinancialJoon Lee$351206% upsideOpen
2022-11-18Oppenheimer$12347.8% upsideOpen
2022-11-18Credit Suisse$13385.1% upsideOpen
2022-11-18Chardan Capital$351206% upsideOpen
2022-01-06Morgan StanleyMatthew Harrison$24795.5% upsideOpen
2021-11-08Robert W. BairdJoel Beatty$441541.8% upsideOpen
2021-09-29Truist FinancialJoon Lee$802885.1% upsideOpen

Editas Medicine (EDIT) FAQ

The latest target price for EDIT is $4. Investors often review this figure alongside Editas Medicine's historical trend and sector peers before judging valuation or financial health.

Editas Medicine trades near $2.68 while the consensus target sits at $4 (49.3% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting EDIT's target price ($4), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Editas Medicine's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.